Display Settings:

Format

Send to:

Choose Destination
    Crit Care. 2009;13(4):311. Epub 2009 Aug 14.

    Targeting the ubiquitin proteasome pathway for the treatment of septic shock in patients.

    Source

    Ottawa Health Research Institute, Ottawa, ON, Canada K1Y 4E9. jzbrun@yahoo.com

    Abstract

    Endotoxic shock is a serious systemic inflammatory response to an external biological stressor. The responsiveness of NF-kappaB is built upon rapid protein modification and degradation involving the ubiquitin proteasome pathway. Using transgenic mice, we have obtained in vivo evidence that interference with this pathway can alleviate the symptoms of toxic shock. We posit that administration of proteasome inhibitors may enhance the survival of patients with septic shock.

    PMID:
    19691815
    [PubMed - indexed for MEDLINE]
    PMCID: PMC2750148
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Figure 1
    Figure 3
    Figure 2

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk